Indeed, increased accumulation of soluble Aβ rather than overproduction is thought to be responsible for AD senile-plaque pathology, due at least in part to impaired Aβ clearance mediated by low IGF1 levels [13]. This evidence concerns the gene IGF1 and Alzheimer disease.